Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
1.
J. coloproctol. (Rio J., Impr.) ; 36(2): 119-121, Apr-Jun. 2016.
Article in English | LILACS | ID: lil-785860

ABSTRACT

Coloprep is a bowel preparatory solution given before endoscopic procedures to get a unobscured internal vision. It has among its constituent's sodium sulphate, potassium sulphate and magnesium sulphate which produce an osmotic effect in the bowel. However, the use of such agents in hyponatremic and patients predisposed to seizures can have adverse ramifications. The current case outlines manifestation of absence seizure in a 52-year-old male patient who was administered Coloprep for colonoscopy. There was absence of other predisposing factors and the symptoms were ameliorated using timely identification and rectification of the underlying derangements.


Coloprep é uma solução preparatória intestinal administrada antes de procedimentos endoscópicos, com o objetivo de se ter uma visão interna não obscurecida. Entre os constituintes de Coloprep, observa-se sulfato de sódio, sulfato de potássio e sulfato de magnésio, que provocam efeito osmótico no intestino. Mas o uso de tais agentes em pacientes hiponatrêmicos e com predisposição para convulsões pode ter ramificações adversas. O caso em tela delineia uma manifestação de convulsão de ausência em paciente do gênero masculino com 52 anos e que recebeu Coloprep para colonoscopia. Não havia outros fatores predisponentes e os sintomas melhoraram graças à oportuna identificação e correção dos transtornos subjacentes.


Subject(s)
Humans , Male , Middle Aged , Seizures/complications , Sulfates/administration & dosage , Cathartics/adverse effects , Colonoscopy/adverse effects , Sodium Compounds/administration & dosage , Potassium Compounds/administration & dosage , Magnesium Sulfate/administration & dosage , Seizures , Sulfates/analysis , Sulfates/adverse effects , Sulfates/therapeutic use , Cathartics/administration & dosage , Cathartics/therapeutic use , Sodium Compounds/analysis , Sodium Compounds/adverse effects , Sodium Compounds/therapeutic use , Potassium Compounds/analysis , Potassium Compounds/adverse effects , Potassium Compounds/therapeutic use , Hyponatremia , Magnesium Sulfate/analysis , Magnesium Sulfate/adverse effects , Magnesium Sulfate/therapeutic use
2.
Braz. oral res. (Online) ; 29(1): 1-7, 2015. tab, ilus
Article in English | LILACS | ID: lil-777205

ABSTRACT

The study aimed to evaluate the effectiveness of in-office bleaching and associated tooth sensitivity on application of nano-calcium phosphate paste as desensitizing agent. Bleaching was performed with 35% hydrogen peroxide gel in 40 patients who were randomly divided into placebo and nano-calcium phosphate paste groups. Bleaching efficacy (BE) was evaluated using a value-oriented Vita shade guide. Tooth sensitivity was recorded using a numeric rating scale (0–4) during bleaching and up to 48 h after each session. The primary outcome of absolute risk of tooth sensitivity was compared using the Fisher’s exact test (α = 0.05). The intensity of tooth sensitivity and the efficacy of in-office bleaching were also statistically evaluated. No significant differences in absolute risk and intensity of tooth sensitivity were detected between the groups (p = 1.0 and p = 0.53, respectively). BE was also found to be similar between the groups (p = 0.67). Although the use of a nano-calcium phosphate paste associated with fluoride and potassium nitrate did not influence the whitening outcome, but it also did not reduce bleaching-induced tooth sensitivity.


Subject(s)
Adult , Female , Humans , Male , Young Adult , Calcium Phosphates/administration & dosage , Dentin Desensitizing Agents/administration & dosage , Dentin Sensitivity/chemically induced , Hydrogen Peroxide/administration & dosage , Nitrates/administration & dosage , Potassium Compounds/administration & dosage , Tooth Bleaching Agents/administration & dosage , Tooth Bleaching/adverse effects , Calcium Phosphates/adverse effects , Double-Blind Method , Hydrogen Peroxide/adverse effects , Nitrates/adverse effects , Potassium Compounds/adverse effects , Tooth Bleaching Agents/adverse effects , Tooth Bleaching/methods , Tooth Discoloration/drug therapy
3.
An. bras. dermatol ; 89(2): 236-240, Mar-Apr/2014. tab, graf
Article in English | LILACS | ID: lil-706969

ABSTRACT

BACKGROUND: Genital warts are caused by human papillomavirus infection and represent one of the most common sexually transmitted diseases. Many infections are transient but the virus may recur, persist, or become latent. To date, there is no effective antiviral treatment to eliminate HPV infection and most therapies are aimed at the destruction of visible lesions. Potassium hydroxide is a strong alkali that has been shown to be safe and effective for the treatment of genital warts and molluscum contagiosum. Cryotherapy is considered one of the most established treatments for genital warts. No comparative trials have been reported to date on the use of potassium hydroxide for genital warts. OBJECTIVE: A prospective, open-label, randomized clinical trial was conducted to compare topical potassium hydroxide versus cryotherapy in the treatment of genital warts affecting immunocompetent, sexually active men. METHODS: Over a period of 10 months, 48 patients were enrolled. They were randomly divided into two groups and selected on an alternative basis for either potassium hydroxide therapy or cryotherapy. While response to therapy did not differ substantially between both treatment modalities, side effects such as local pain and post-treatment hypopigmentation were considerably more prevalent in the groups treated using cryotherapy. Result: In our study, potassium hydroxide therapy proved to be at least as effective as cryotherapy and offered the benefit of a better safety profile. CONCLUSION: Topical 5% potassium hydroxide presents an effective, safe, and low-cost treatment modality for genital warts in men and should be included in the spectrum of therapies for genital warts. .


Subject(s)
Adolescent , Adult , Aged , Humans , Male , Middle Aged , Young Adult , Condylomata Acuminata/therapy , Cryotherapy/methods , Dermatologic Agents/administration & dosage , Genital Diseases, Male/therapy , Hydroxides/administration & dosage , Potassium Compounds/administration & dosage , Administration, Topical , Chi-Square Distribution , Dose-Response Relationship, Drug , Dermatologic Agents/therapeutic use , Follow-Up Studies , Hydroxides/therapeutic use , Prospective Studies , Potassium Compounds/therapeutic use , Reproducibility of Results , Treatment Outcome
4.
Indian J Physiol Pharmacol ; 2005 Jul-Sep; 49(3): 284-8
Article in English | IMSEAR | ID: sea-106777

ABSTRACT

Nitrate is a wide spread contaminant of ground and surface water. The source of nitrate in the ground water may be from run off or seepage from fertilized soil, municipal or industrial waste water, land fills, septic system, urban drainage or decaying plants. Human and animal systems are affected severely on nitrate exposure. The study was to investigate the effect of dietary nitrate exposure on the thyroid status along with the state of iodine nutrition. Rats were fed diet containing 3% potassium nitrate (KNO3) for 4 weeks and then thyroid status was evaluated by thyroid gland weight, urinary iodine excretion pattern, thyroid peroxidase (TPO) activity, serum levels of total thyroxine (T4), triiodothyronine (T3) and thyroid stimulating hormone (TSH) concentrations. In nitrate treated animals, the weight of thyroid gland was increased significantly (P<0.001) while thyroid peroxidase activity (P<0.01), serum T4 (P<0.01) and serum T3 levels (P<0.001) were reduced; but serum TSH level was increased (P<0.001) along with slightly elevated iodine excretion level (P<0.001) in comparison to control animals. The overall results indicated the development of a relative state of functional hypothyroidism with enlarged thyroid after nitrate exposure. This study can explain a part for the persistence of residual goitre in the post-salt iodization phase.


Subject(s)
Animals , Body Weight , Diet , Environmental Pollutants/toxicity , Goiter/etiology , Hypothyroidism/blood , Iodide Peroxidase/metabolism , Iodine/physiology , Nitrates/administration & dosage , Organ Size , Potassium Compounds/administration & dosage , Rats , Rats, Wistar , Thyroid Gland/drug effects , Thyrotropin/blood , Thyroxine/blood , Triiodothyronine/blood , Water Pollutants, Chemical
5.
Article in English | IMSEAR | ID: sea-93782

ABSTRACT

Hypokalemic paralysis is an uncommon entity with varied etiology. Renal tubular acidosis is an unusual cause of this disorder. Its occurrence with pregnancy is rare. We report such a case and mention the implications of the association and review relevant literature breifly.


Subject(s)
Acidosis, Renal Tubular/complications , Adult , Embryonic and Fetal Development/physiology , Female , Fetal Death , Gestational Age , Humans , Hypokalemia/diagnosis , Paralysis/diagnosis , Potassium Compounds/administration & dosage , Pregnancy , Pregnancy Complications/diagnosis , Prenatal Diagnosis/methods , Risk Assessment
SELECTION OF CITATIONS
SEARCH DETAIL